Canadian Pharma Co.'s Units File $61M Ch. 15 In Delaware
By Aaron Keller · January 30, 2023, 7:22 PM EST
Citing $61.5 million in total liabilities and a looming liquidity crisis, the American arm of Ontario-based Acerus Pharmaceuticals Corp. filed a Chapter 15 bankruptcy petition in Delaware on Sunday in connection...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login